-
Signature
-
Gregory Scott Thomas
-
Issuer symbol
-
CRUS
-
Transactions as of
-
02 Mar 2025
-
Net transactions value
-
-$496,565
-
Form type
-
4
-
Filing time
-
04 Mar 2025, 18:37:46 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRUS |
Common Stock |
Options Exercise |
$0 |
+4,079 |
+17% |
$0.000000 |
28,054 |
02 Mar 2025 |
Direct |
F1 |
| transaction |
CRUS |
Common Stock |
Tax liability |
$108,274 |
-1,039 |
-3.7% |
$104.21 |
27,015 |
02 Mar 2025 |
Direct |
F2 |
| transaction |
CRUS |
Common Stock |
Options Exercise |
$0 |
+3,031 |
+11% |
$0.000000 |
30,046 |
02 Mar 2025 |
Direct |
|
| transaction |
CRUS |
Common Stock |
Tax liability |
$77,011 |
-739 |
-2.5% |
$104.21 |
29,307 |
02 Mar 2025 |
Direct |
F2 |
| transaction |
CRUS |
Common Stock |
Sale |
$311,280 |
-3,000 |
-10% |
$103.76 |
26,307 |
03 Mar 2025 |
Direct |
F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRUS |
Performance Shares |
Options Exercise |
$0 |
-2,443 |
-25% |
$0.000000 |
7,191 |
02 Mar 2025 |
Common Stock |
2,443 |
|
Direct |
F5, F6 |
| transaction |
CRUS |
Restricted Stock Units |
Options Exercise |
$0 |
-3,031 |
-22% |
$0.000000 |
11,058 |
02 Mar 2025 |
Common Stock |
3,031 |
|
Direct |
F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: